Literature DB >> 23021216

c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.

Zuqin Nie1, Gangqing Hu, Gang Wei, Kairong Cui, Arito Yamane, Wolfgang Resch, Ruoning Wang, Douglas R Green, Lino Tessarollo, Rafael Casellas, Keji Zhao, David Levens.   

Abstract

The c-Myc HLH-bZIP protein has been implicated in physiological or pathological growth, proliferation, apoptosis, metabolism, and differentiation at the cellular, tissue, or organismal levels via regulation of numerous target genes. No principle yet unifies Myc action due partly to an incomplete inventory and functional accounting of Myc's targets. To observe Myc target expression and function in a system where Myc is temporally and physiologically regulated, the transcriptomes and the genome-wide distributions of Myc, RNA polymerase II, and chromatin modifications were compared during lymphocyte activation and in ES cells as well. A remarkably simple rule emerged from this quantitative analysis: Myc is not an on-off specifier of gene activity, but is a nonlinear amplifier of expression, acting universally at active genes, except for immediate early genes that are strongly induced before Myc. This rule of Myc action explains the vast majority of Myc biology observed in literature.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23021216      PMCID: PMC3471363          DOI: 10.1016/j.cell.2012.08.033

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  58 in total

Review 1.  Making myc.

Authors:  J Liu; D Levens
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

2.  ChIP-on-chip significance analysis reveals large-scale binding and regulation by human transcription factor oncogenes.

Authors:  Adam A Margolin; Teresa Palomero; Pavel Sumazin; Andrea Califano; Adolfo A Ferrando; Gustavo Stolovitzky
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-31       Impact factor: 11.205

3.  Large induction of c-Myc is not essential for the mitogenic response of Swiss 3T3 fibroblasts.

Authors:  H Mehmet; T D Littlewood; J Sinnett-Smith; J P Moore; G I Evan; E Rozengurt
Journal:  Cell Growth Differ       Date:  1997-02

4.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

5.  Transcriptional repression: the dark side of myc.

Authors:  Barbara Herkert; Martin Eilers
Journal:  Genes Cancer       Date:  2010-06

Review 6.  The c-myc promoter: still MysterY and challenge.

Authors:  Inken Wierstra; Jürgen Alves
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

7.  Contributions of transcriptional and post-transcriptional mechanisms to the regulation of c-myc expression in mouse erythroleukemia cells.

Authors:  A Nepveu; K B Marcu; A I Skoultchi; H M Lachman
Journal:  Genes Dev       Date:  1987-11       Impact factor: 11.361

8.  A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells.

Authors:  Zirong Li; Sara Van Calcar; Chunxu Qu; Webster K Cavenee; Michael Q Zhang; Bing Ren
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

9.  Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle.

Authors:  P H Rabbitts; J V Watson; A Lamond; A Forster; M A Stinson; G Evan; W Fischer; E Atherton; R Sheppard; T H Rabbitts
Journal:  EMBO J       Date:  1985-08       Impact factor: 11.598

10.  Searching for SNPs with cloud computing.

Authors:  Ben Langmead; Michael C Schatz; Jimmy Lin; Mihai Pop; Steven L Salzberg
Journal:  Genome Biol       Date:  2009-11-20       Impact factor: 13.583

View more
  545 in total

1.  Low expression of miR-let-7a promotes cell growth and invasion through the regulation of c-Myc in oral squamous cell carcinoma.

Authors:  Chunyang Luo; Jiyong Zhang; Yi Zhang; Xiao Zhang; Yinan Chen; Weimin Fan
Journal:  Cell Cycle       Date:  2020-06-28       Impact factor: 4.534

Review 2.  MYC: connecting selective transcriptional control to global RNA production.

Authors:  Theresia R Kress; Arianna Sabò; Bruno Amati
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

3.  Targeting c-MYC in Platinum-Resistant Ovarian Cancer.

Authors:  Jeyshka M Reyes-González; Guillermo N Armaiz-Peña; Lingegowda S Mangala; Fatma Valiyeva; Cristina Ivan; Sunila Pradeep; Ileabett M Echevarría-Vargas; Adrian Rivera-Reyes; Anil K Sood; Pablo E Vivas-Mejía
Journal:  Mol Cancer Ther       Date:  2015-07-30       Impact factor: 6.261

4.  Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis.

Authors:  Joanne R Doherty; Chunying Yang; Kristen E N Scott; Michael D Cameron; Mohammad Fallahi; Weimin Li; Mark A Hall; Antonio L Amelio; Jitendra K Mishra; Fangzheng Li; Mariola Tortosa; Heide Marika Genau; Robert J Rounbehler; Yunqi Lu; Chi V Dang; K Ganesh Kumar; Andrew A Butler; Thomas D Bannister; Andrea T Hooper; Keziban Unsal-Kacmaz; William R Roush; John L Cleveland
Journal:  Cancer Res       Date:  2013-11-27       Impact factor: 12.701

5.  Global Inhibition with Specific Activation: How p53 and MYC Redistribute the Transcriptome in the DNA Double-Strand Break Response.

Authors:  Joshua R Porter; Brian E Fisher; Laura Baranello; Julia C Liu; Diane M Kambach; Zuqin Nie; Woo Seuk Koh; Ji Luo; Jayne M Stommel; David Levens; Eric Batchelor
Journal:  Mol Cell       Date:  2017-08-31       Impact factor: 17.970

Review 6.  Mechanisms underlying the formation of induced pluripotent stem cells.

Authors:  Federico González; Danwei Huangfu
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-09-18       Impact factor: 5.814

Review 7.  The MYC-WDR5 Nexus and Cancer.

Authors:  Lance R Thomas; Audra M Foshage; April M Weissmiller; William P Tansey
Journal:  Cancer Res       Date:  2015-09-17       Impact factor: 12.701

Review 8.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

9.  Loss of Nmp4 optimizes osteogenic metabolism and secretion to enhance bone quality.

Authors:  Yu Shao; Emily Wichern; Paul J Childress; Michele Adaway; Jagannath Misra; Angela Klunk; David B Burr; Ronald C Wek; Amber L Mosley; Yunlong Liu; Alexander G Robling; Nickolay Brustovetsky; James Hamilton; Kylie Jacobs; Deepak Vashishth; Keith R Stayrook; Matthew R Allen; Joseph M Wallace; Joseph P Bidwell
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-01-15       Impact factor: 4.310

10.  Myeloid leukemia with transdifferentiation plasticity developing from T-cell progenitors.

Authors:  Pia Riemke; Melinda Czeh; Josephine Fischer; Carolin Walter; Saeed Ghani; Matthias Zepper; Konstantin Agelopoulos; Stephanie Lettermann; Marie L Gebhardt; Nancy Mah; Andre Weilemann; Michael Grau; Verena Gröning; Torsten Haferlach; Dido Lenze; Ruud Delwel; Marco Prinz; Miguel A Andrade-Navarro; Georg Lenz; Martin Dugas; Carsten Müller-Tidow; Frank Rosenbauer
Journal:  EMBO J       Date:  2016-08-29       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.